Register or Sign in to Save this opportunity, or Send an Inquiry.
Novel Embolizing Therapy for the Ablation of Solid Tumors (Ref # WFU 11-47)
Wake Forest Innovations United States flag United States
Abstract ID:
Technology is the first to combine nanoparticles, radiofrequency, and embolization to destroy cancerous tissue and treat vascular-related disorders in a highly specific manner.
Send an Inquiry
RE:
Participants
You

Novel Embolizing Therapy for the Ablation of Solid Tumors


Value Proposition


A common issue in the treatment of cancer is the unregulated toxic effects many therapies elicit on healthy tissues, without fully destroying the entire tumor. In addition, while studies show effective cell death with nanoparticle-based technologies, these particles frequently leech out of the target site into unintended regions of the body. This is due to the lack of a developed fixing agent to maintain nanoparticles locally in the tissue. This technology is the first to combine nanoparticles, radiofrequency, and embolization to destroy cancerous tissue and treat vascular-related disorders in a highly specific manner.


Invention Summary


Researchers have developed a technology that combines a nanoparticle-embedded embolizing agent with radiofrequency-stimulated thermal ablation to destroy vascularized tumors or unhealthy tissues.


Competitive Benefits


GO PREMIUM TO GET PATENT INFORMATION
Type of Business Relationship Sought

 

Exclusive Licensing Arrangement

Possibility of a parallel Sponsored Research Agreement

Contact 

Charlie Shaw, PhD

Wake Forest Innovations

Commercialization Associate

Tel:  +1.336.716.3729

Email: chshaw@wakehealth.edu

 

 

FEATURED
Last Updated Feb 2014
Technology Type THERAPEUTIC
Phase of Development PRECLINICAL
CORPORATION

Opportunity Contact